Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-22-009813
Filing Date
2022-04-21
Accepted
2022-04-21 14:13:01
Documents
3
Period of Report
2022-04-21

Document Format Files

Seq Description Document Type Size
1 6-K cybininc-form6xk04x21x2022.htm 6-K 14048
2 EX-99.1 cybncyb003clinilabspartner.htm EX-99.1 18913
3 image_0.jpg GRAPHIC 486418
  Complete submission text file 0001628280-22-009813.txt   704053
Mailing Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9
Business Address 100 KING STREET WEST SUITE 5600 TORONTO A6 M5X 1C9 (908) 764-8385
CYBIN INC. (Filer) CIK: 0001833141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-40673 | Film No.: 22840975
SIC: 2834 Pharmaceutical Preparations